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The data presented in this brief report support the research article
“Altered mitochondrial and peroxisomal integrity in lipocalin-2-deﬁcient
mice with hepatic steatosis” [1, doi: http://dx.doi.org/10.1016/j.bbadis.
2017.04.006]. We tested whether the absence of Lipocalin-2 (LCN2)
could dysregulate the phosphatidylinositol 3-kinase/protein kinase B
(PI3K-PKB) pathway and hepatic homeostasis in Non-Alcoholic-
Steatohepatitis (NASH). The article highlights the role of LCN2 in
hepatic homeostasis.
& 2017 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc
subject areaLiver biologyier Inc. This is an open access article under the CC BY license
/j.bbadis.2017.04.006
Weiskirchen).
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A. Asimakopoulou et al. / Data in Brief 13 (2017) 644–649 645ype of data Figures (Immunoﬂuorescence staining, Western blot analysis)
ow data was
acquiredMicroscope (Nikon ECLIPSE 80i)
Chemiluminescent detection (Boehringer Mannheim GmbH Lumi-Imager)ata format Raw
xperimental
factorsLiver sections were derived from WT and Lcn2-/- mice [2] after feeding a MCD or
standard chow diet for 6 weeks.
Protein extracts were prepared from the same livers for Western blot analysis.
Hepatocytes were isolated from WT and Lcn2-/- mice for in vitro experimentation.xperimental
featuresLiver sections from WT and Lcn2-/- mice were immunostained for PIP3. Negative
and positive controls were also used.
100 mg of protein extracts from livers were used to detect PKB, phospho PKB, LCN2
and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) by Western blot.
Hepatocytes were cultured from WT and Lcn2-/- mice. These were left untreated or
treated with bovine insulin to induce PI3K and PIP3. Respective cells were
immunostained for PIP3.ata source
locationAachen, Germanyata accessibility Data not deposited elsewhere outside this article. Primary data are published
in [1].Value of the data
 LCN2 is a versatile molecule participating in several pathways of hepatic homeostasis. The data
describe the regulation of the PI3K/PIP3/PKB pathway with regard to the presence of LCN2 in a
NASH model.
 The data study the value of LCN2 in PI3K signaling in NASH.
 The data are useful to understand how the absence of LCN2 affects PIP3 production.
 Signaling analyses could lead to novel treatment strategies to modulate medical conditions where
the PI3K-PKB signaling pathway is dysregulated such as fatty liver and diabetes type 2 [3].
 The data presented in this article, could be compared with data from other animal NASH models to
verify the strength of the effect. Moreover, comparison of this data to human NASH data on PI3K
signaling and PIP3 functions could drive the development of novel LCN2 targeted therapies.1. Data
The data include protein detection of members of the PI3K signaling and PIP3 quantiﬁcation
(Figs. 1-3). The detection of respective biomolecules was done with ﬂuorescence immunohis-
tochemistry/immunocytochemistry and Western blot. The analyzed liver sections and primary
hepatocytes originated from WT and Lcn2-/- mice fed on a standard chow diet or an MCD diet. The
hepatocytes were treated with insulin to trigger PIP3 and PI3K before immunodetection. Untreated
control cells were used to compare.2. Experimental design, materials and methods
2.1. Liver cryosections
Mice, WT and LCN2 deﬁcient, were sacriﬁced under isoﬂurane (Forenes) anaesthesia (Abbott,
Wiesbaden, Germany), and whole livers were resected. The livers were snap frozen in liquid nitrogen
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The Netherlands) and kept at 80 °C. The snap frozen tissues were sliced into 5 μm standard sections
and kept at 80 °C.
2.2. Cell culture and PIP3 stimulation
Primary hepatocytes from WT or Lcn2-/- mice were isolated using the collagenase method of
Seglen [5]. The hepatocytes were seeded on collagenase-coated cover slips in 6-well plates with
HepatoZYME SFM (Thermo Fisher Scientiﬁc, Dreieich, Germany) supplemented with 2 mM L-
glutamine (Sigma Aldrich, Taufkirchen, Germany) and 1% penicillin/streptomycin (Sigma Aldrich).
They were cultivated for 2 days at 37 °C in incubator conditions of 5% CO2 and 100% humidity.
Hepatocytes were left untreated or stimulated with bovine insulin (2 mg/ml) (Sigma Aldrich) for
30 min to trigger activation of PI3K and formation of PIP3 [6]. Stimulated hepatocytes were washed
three times with ice cold PBS and ﬁxed in 4% paraformaldehyde for 20 min at room temperature. As a
control, MDA-MB-231 breast cancer cells [4], which are known to be highly sensitive to insulin [7],
were cultivated in Dulbecco's Modiﬁed Eagle's medium (Sigma Aldrich) supplemented with 10% fetal
bovine serum (Sigma Aldrich) prior to stimulation and ﬁxation as described above.
2.3. Immunodetection of PIP3
PIP3 quantiﬁcation in ﬁxed cells and cryosections was performed using standard immunocyto-
chemical methods [8]. Brieﬂy, ﬁxed cells and cryosections were washed three times with Tris-
buffered saline (TBS), permeabilized in 0.5% saponin (Sigma Aldrich, cat. no. 47063-506-F) for 15 min
at room temperature, and washed again three times with TBS. Cells were blocked with 10% (v/v)
normal goat serum (DAKO, Hamburg, Germany, cat. no. X0907) in TBS for 1 h at 37 °C, followed by
three washes in TBS containing 1% (v/v) normal goat serum. Samples were incubated overnight at 4 °C
in TBS containing a 1:100 dilution of a mouse anti-PIP3 monoclonal antibody (Echelon Biosciences
Inc., Salt Lake City, UT, USA, cat. no. Z-P345), 1% (w/v) bovine serum albumin (BSA) (Sigma Aldrich),
and 1% (v/v) normal goat serum, respectively. This monoclonal antibody reacts primarily with the
head group of PIP3 and has low cross-reactivity with other phosphoinositides [9]. Samples were
washed three times in TBS containing 1% BSA and 1% normal goat serum and incubated for 1 h at RT
with a TRITC-conjugated Afﬁni Pure goat anti-mouse IgM speciﬁc for the m chain (Jackson Immu-
noResearch Laboratories Inc., Dianova, Hamburg, Germany, cat. no. 115-025-020) at a dilution of
1:200 in TBS supplemented with 1% BSA and 1% normal goat serum. After washes in TBS and distilled
water, stained cells were mounted in mounting medium with DAPI (Vector Laboratories Inc., Bur-
lingame, CA, cat. no. H-1200) .
2.4. Western blot
Equal amounts of total protein 100 μg/lane from liver tissue extracts were mixed with Nu-PAGE™
LDS electrophoresis sample buffer containing dithiothreitol as a reducing agent. Samples were heated
at 87 °C for 10 min before fractionation on 4–12% Bis-Tris gels in 2-(N-morpholino) ethanesulfonic
acid (MES) running buffer (Roth, Karlsruhe, Germany). Proteins were electroblotted onto a Protran
membrane (GE Healthcare, Freiburg im Breisgau, Germany), and equal protein loading was conﬁrmed
by Ponceau S (Sigma) staining. For Western blotting, the membranes were ﬁrst blocked by incubation
in TBS supplemented with 1% Tween20 (TBST), containing 5% (w/v) non-fat milk powder (Roth).
Primary antibodies used were: PKB (Cell Signaling Technology, Danvers, MA, USA, cat. no. 4685), p-
PKB (Cell Signaling Technology, cat. no. 4060), LCN2 (R&D Systems, Minneapolis, MN, USA, cat. no
AF3508), and GAPDH (Santa Cruz Biotech., Santa Cruz, CA, USA, cat. no sc-32233). The antibodies were
pPKB (60 kDa)
total PKB (60 kDa)
LCN2 (25 kDa)
GAPDH (37 kDa)
4 weeks 6 weeks
wc kc wm km wc kc wm km
Fig. 2. Visualization of expression of selected proteins by Western blot analysis. Protein extracts were prepared from livers of
WT and Lcn2-/- mice that were subjected to indicated diets for 4 or 6 weeks (n¼3 animals/group). Antibodies used are
mentioned in the Section 2. GAPDH was used as the loading control.
Fig. 1. Immunodetection of phosphoinositide (3,4,5) triphosphate (PIP3) in liver cryosections. Immunostaining with a tetra-
methylrhodamine (TRITC)-conjugated antibody to detect PIP3 in mouse liver cryosections of each group (wc ¼ wild type
mouse standard diet; wm ¼ wild type mouse MCD diet, kc ¼ Lcn2-/- mouse standard diet and km ¼ Lcn2-/- mouse MCD diet).
Nuclei were counterstained with 40 ,6-diamidino-2-phenylindole (DAPI). As a negative control, non-speciﬁc antiserumwas used
for staining. Scale bars, 50 mm.
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membrane. Primary antibodies were visualized with anti-mouse-, anti-rabbit or anti-goat IgG sec-
ondary antibodies (all from Santa Cruz Biotech, CA cat. nos. sc-2004, sc-2005, sc-2056) in the Lumi-
Imager (Roche Diagnostics, Darmstadt, Germany) using the SuperSignal chemiluminescent substrate
(Thermo Fisher Scientiﬁc).Funding sources
This work was ﬁnancially supported by Grants from the German Research Foundation (SFB TRR57,
P13 and Q03) and the Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at
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Fig. 3. Immunodetection of PIP3 in cultured hepatocytes. Cultured hepatocytes isolated from WT or Lcn2-deﬁcient animals fed
normal chow were left untreated () or stimulated with 2 mg/ml bovine insulin (þ) for 30 min. PIP3 in ﬁxed cells was detected
immunocytochemically using a tetramethylrhodamine (TRITC)-conjugated goat anti-mouse IgM speciﬁc for PIP3. Nuclei were
counterstained with DAPI. The highly sensitive to insulin breast cancer cell line MDA-MB-231 [4] was used as a positive control.
Immunostaining with a non-speciﬁc antiserum served as a negative control (data not shown). Scale bars, 100 mm.
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